Drawing for Serial No. 79013174

USPTO serial 79013174

Serial No. 79013174

Reviewed by CopyMark Law Group

Reg. 3154308Status 404
Filing date
Status date
Registration date
Oct 10, 2006
Examiner
KHOURI, SANI PHILIPPE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79013174?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donald S. Gardner

Donald S. Gardner Gardner, Linn, Burkhart & Flory, LLP2851 Charlevoix Drive, S.E.Suite 207Grand Rapids, MI 49546

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances administered for rhesus prophylaxis and for the treatment of human autoimmune disorders; blood products, namely, plasma volume expanders, blood plasma, human albumin, blood clotting factors and immunoglobulins administered for rhesus prophylaxis and for the treatment of human autoimmune disorders; products derived from recombinant DNA technology, namely, plasma volume expanders; human albumin, blood clotting factors and immunoglobulins administered for rhesus prophylaxis and for the treatment of human autoimmune disordersSECTION 71 - CANCELLED
016Printed matter and publications, namely books, magazines, newsletters, brochures, leaflets and periodicals, all featuring material in relation to pharmaceutical products, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; printed educational and teaching material in the field of pharmaceutical products, blood, blood products, bleeding disorders, blood fractionation, rhesus prophylaxis and human autoimmune disorders; stationery; calendars and postersSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 13, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 13, 2015DETHDEATH OF INTERNATIONAL REGISTRATION
Sep 30, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB
Sep 30, 2014XXCRGENERIC MADRID TRANSACTION CREATED
May 20, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 20, 2013C71TCANCELLED SECTION 71
Sep 21, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 25, 2008CHLDCHANGE OF OWNER RECEIVED FROM IB
Jun 1, 2007FINVFINAL DECISION TRANSACTION PROCESSED BY IB
May 10, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
May 10, 2007FIMPFINAL DISPOSITION PROCESSED
May 9, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 10, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2006NPUBNOTICE OF PUBLICATION
May 24, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2006ALIEASSIGNED TO LIE
May 17, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2006ACECAMENDMENT FROM APPLICANT ENTERED
Mar 13, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2006MAILPAPER RECEIVED
Mar 8, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2005RFNTREFUSAL PROCESSED BY IB
Sep 16, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 15, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 6, 2005DOCKASSIGNED TO EXAMINER
Sep 6, 2005NWAPNEW APPLICATION ENTERED
Sep 1, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance